Cercar
01/02/2022
The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients
Dunn, WG, Gu, MXS, Fabre, MA, Cooper, J, Nomdedeu, JF, Koumas, L, Nicolaou, K, Chi, JX, Costeas, P, Vassiliou, GS. The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients. ANNALS OF HEMATOLOGY. 2022; 101(2)DOI:10.1007/s00277-021-04472-5. PMID:33650061. IF:3.500(Q2/5D).
14/12/2021
Engraftment characterization of risk-stratified AML in NSGS mice
de la Guardia, RD, Velasco-Hernandez, T, Gutierrez-Aguera, F, Roca-Ho, H, Molina, O, Nombela-Arrieta, C, Bataller, A, Fuster, JL, Anguita, E, Vives, S, Zamora, L, Nomdedeu, J, Gomez-Casares, MT, Ramirez-Orellana, M, Lapillonne, H, Ramos-Mejia, V, Rodriguez-Manzaneque, JC, Bueno, C, Lopez-Millan, B, Menendez, P. Engraftment characterization of risk-stratified AML in NSGS mice. Blood Advances. 2021; 5(23)DOI:10.1182/bloodadvances.2020003958. PMID:34470043. IF:7.642(Q1/3D).
10/08/2021
The evolution of hematopoietic cells under cancer therapy
Pich, O, Cortes-Bullich, A, Muinos, F, Pratcorona, M, Gonzalez-Perez, A, Lopez-Bigas, N. The evolution of hematopoietic cells under cancer therapy. Nature Communications. 2021; 12(1)DOI:10.1038/s41467-021-24858-3. PMID:34376657. IF:17.694(Q1/1D).
01/08/2021
Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations
Martin, I, Villamon, E, Abellan, R, Calasanz, MJ, Irigoyen, A, Sanz, G, Such, E, Mora, E, Gutierrez, M, Collado, R, Garcia-Serra, R, Vara, M, Blanco, ML, Oiartzabal, I, Alvarez, S, Bernal, T, Granada, I, Xicoy, B, Jerez, A, Calabuig, M, Diez, R, Gil, A, Diez-Campelo, M, Solano, C, Tormo, M. Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations. BRITISH JOURNAL OF HAEMATOLOGY. 2021; 194(4)DOI:10.1111/bjh.17675. PMID:34296432. IF:8.615(Q1/2D).
01/07/2021
Sickle cell nephropathy. Clinical manifestations and new mechanisms involved in kidney injury
Payan-Pernia, S, Llobet, AR, Sevilla, AFR, Egido, J, Castan, JAB, Moreno, JA. Sickle cell nephropathy. Clinical manifestations and new mechanisms involved in kidney injury. NEFROLOGIA. 2021; 41(4)DOI:10.1016/j.nefro.2020.10.012. PMID:33714630. IF:3.084(Q2/5D).
01/10/2025
Diagnostic Value of Botryoid Nuclei as a Biomarker of Severe Hyperthermia and Systemic Inflammation in Heatstroke and Neuroleptic Malignant Syndrome: A Challenge of Climate Change
Verdú, G, Vallvé, M, San-José, P, Molina, A, Merino, A. Diagnostic Value of Botryoid Nuclei as a Biomarker of Severe Hyperthermia and Systemic Inflammation in Heatstroke and Neuroleptic Malignant Syndrome: A Challenge of Climate Change. International Journal of Laboratory Hematology. 2025; 47(5)DOI:10.1111/ijlh.14500. PMID:40391693. IF:2.300(Q2/5D).
01/09/2025
Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis
Mcloughlin, MA, Kovilakam, SC, Dunn, WG, Gu, MX, Tobin, J, Pershad, Y, Williams, N, Leongamornlert, D, Dawson, K, Bond, L, Marando, L, Wen, S, Wilson, R, Valenzano, G, Symeonidou, V, Rak, J, Damaskou, A, Gozdecka, M, Liu, XX, Barcena, C, Nomdedeu, J, Costeas, P, Dimitriou, ID, Fiorillo, E, Orrù, V, de Almeida, JG, Mckerrell, T, Cullen, M, Mohorianu, I, Foukaneli, T, Warren, AJ, Wong, C, Follows, G, Godfrey, AL, Gudgin, E, Cucca, F, Mckinney, E, Baxter, EJ, Gerstung, M, Mitchell, J, Wiseman, D, Bick, AG, Fabre, M, Quiros, PM, Nangalia, J, Kar, S, Vassiliou, GS. Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis. NATURE GENETICS. 2025; 57(9)DOI:10.1038/s41588-025-02296-x. PMID:40877435. IF:29.000(Q1/1D).
01/05/2025
D816V KIT mutation induces mitochondrial morphologic and functional changes through BNIP3 downregulation in human myeloid cell lines ROSA and TF-1
Wieczorek, SC, Hernández-Alvarez, MI, Parreño, M, Muñoz, JP, Bussaglia, E, Carricondo, M, Ubeda, J, Dubreuil, P, Zorzano, A, Brenet, F, Nomdedeu, JF. D816V KIT mutation induces mitochondrial morphologic and functional changes through BNIP3 downregulation in human myeloid cell lines ROSA and TF-1. EXPERIMENTAL HEMATOLOGY. 2025; 145DOI:10.1016/j.exphem.2025.104748. PMID:39986568. IF:2.100(Q3/6D).
19/08/2024
Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients
Halik, A, Tilgner, M, Silva, P, Estrada, N, Altwasser, R, Jahn, E, Heuser, M, Hou, HA, Pratcorona, M, Hills, RK, Metzeler, KH, Fenwarth, L, Dolnik, A, Terre, C, Kopp, K, Blau, O, Szyska, M, Christen, F, Krönke, J, Vasseur, L, Löwenberg, B, Esteve, J, Valk, PJM, Duchmann, M, Chou, WC, Linch, DC, Döhner, H, Gale, RE, Döhner, K, Bullinger, L, Yoshida, K, Damm, F. Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients. Journal of Hematology & Oncology. 2024; 17(1)DOI:10.1186/s13045-024-01590-1. PMID:39160538. IF:40.400(Q1/1D).
04/07/2024
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY study
Hernández-Sánchez, A, González, T, Sobas, M, Sträng, E, Castellani, G, Abáigar, M, Valk, PJM, Ramiro, AV, Benner, A, Metzeler, KH, Azibeiro, R, Tettero, JM, Martínez-López, J, Pratcorona, M, Elicegui, JM, Mills, KI, Thiede, C, Sanz, G, Döhner, K, Heuser, M, Haferlach, T, Turki, AT, Reinhardt, D, Schulze-Rath, R, Barbus, M, Hernández-Rivas, JM, Huntly, B, Ossenkoppele, G, Döhner, H, Bullinger, L. Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY study. LEUKEMIA. 2024; 38(9)DOI:10.1038/s41375-024-02333-4. PMID:38965370. IF:13.400(Q1/1D).
03/06/2024
Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infection
Abril, AG, Alejandre, J, Mariscal, A, Alserawan, L, Rabella, N, Roman, E, Lopez-Contreras, J, Navarro, F, Serrano, E, Nomdedeu, JM, Vidal, S. Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infection. Scientific Reports. 2024; 14(1)DOI:10.1038/s41598-024-59634-y. PMID:38830902. IF:3.900(Q1/2D).
01/06/2024
Be aware of the X: BCOR mutations in myeloid neoplasms
Ramil, G, Pratcorona, M, Nomdedéu, JF. Be aware of the X: BCOR mutations in myeloid neoplasms. HAEMATOLOGICA. 2024; 109(6)DOI:10.3324/haematol.2023.284748. PMID:38328862. IF:10.100(Q1/2D).
01/04/2024
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification
Orgueira, AM, Encinas, MMP, Varela, ND, Wang, YH, Mora, E, Diaz-Beya, M, Montoro, MJ, Marin, HP, Ortega, FR, Tormo, M, Jerez, A, Nomdedeu, J, Sanchez, CD, Arenillas, L, Carcel, P, Romero, MTC, Cirici, BX, Arango, ER, Barreto, RAD, Benlloch, L, Lin, CC, Tien, HF, Míguez, CP, Crucitti, D, Campelo, MD, Valcárcel, D. Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification. BRITISH JOURNAL OF HAEMATOLOGY. 2024; 204(4)DOI:10.1111/bjh.19341. PMID:38411250. IF:3.800(Q1/3D).
01/10/2023
Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes
Orgueira, AM, Encinas, MMP, Varela, NAD, Mora, E, Díaz-Beyá, M, Montoro, MJ, Pomares, H, Ramos, F, Tormo, M, Jerez, A, Nomdedeu, JF, Sanchez, CD, Leonor, A, Cárcel, P, Romero, MTC, Xicoy, B, Rivero, E, Barreto, RAD, Diez-Campelo, M, Benlloch, LE, Crucitti, D, Valcárcel, D. Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes. Hemasphere. 2023; 7(10)DOI:10.1097/HS9.0000000000000961. PMID:37841754. IF:11.900(Q1/1D).
01/08/2023
Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion
Castillo M.I., Ribate V.E., Muñoz C.M., Santillana S.G., Taboada S.E., Casterá M.E., Abinzano C.M.J., Barranco I.A., Nieto C.R., Pampliega V.M., Blanco M.L., de Andrés Á.S., de Oteyza P.J., del Castillo B.T., Font G.I., Cayuela J.A., Díez-Campelo M., Sánchez A.R., Vercet S.C., Díaz T.M.. Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion. Cancer Medicine. 2023; 12(16)DOI:10.1002/cam4.6300. PMID:37403747. IF:2.900(Q2/5D).
01/01/2023
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis
Mosquera-Orgueira, A, Perez-Encinas, M, Hernandez-Sanchez, A, Gonzalez-Martinez, T, Arellano-Rodrigo, E, Martinez-Elicegui, J, Villaverde-Ramiro, A, Raya, JM, Ayala, R, Ferrer-Marin, F, Fox, ML, Velez, P, Mora, E, Xicoy, B, Mata-Vazquez, MI, Garcia-Fortes, M, Angona, A, Cuevas, B, Senin, MA, Ramirez-Payer, A, Ramirez, MJ, Perez-Lopez, R, de Villambrosia, SG, Martinez-Valverde, C, Gomez-Casares, MT, Garcia-Hernandez, C, Gasior, M, Bellosillo, B, Steegmann, JL, Alvarez-Larran, A, Hernandez-Rivas, JM, Hernandez-Boluda, JC. Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis. Hemasphere. 2023; 7(1)DOI:10.1097/HS9.0000000000000818. PMID:36570691. IF:11.900(Q1/1D).
01/01/2023
Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency
Marin-Bejar O., Romero-Moya D., Rodriguez-Ubreva J., Distefano M., Lessi F., Aretini P., Liquori A., Castaño J., Kozyra E., Kotmayer L., Bueno C., Cervera J., Rodriguez-Gallego J.C., Nomdedeu J.F., Murillo-Sanjuán L., De Heredia C.D., Pérez-Martinez A., López-Cadenas F., Martínez-Laperche C., Dorado-Herrero N., Marco F.M., Prósper F., Menendez P., Valcárcel D., Ballestar E., Bödör C., Bigas A., Catalá A., Wlodarski M.W., Giorgetti A.. Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency. HAEMATOLOGICA. 2023; 108(9)DOI:10.3324/haematol.2022.282305. PMID:36815365. IF:10.100(Q1/2D).
11/08/2022
Clinical, histological and molecular profiling of different stages of alcohol-related liver disease
Ventura-Cots, M, Argemi, J, Jones, PD, Lackner, C, El Hag, M, Abraldes, JG, Alvarado, E, Clemente, A, Ravi, S, Alves, A, Alboraie, M, Altamirano, J, Barace, S, Bosques, F, Brown, R, Caballeria, J, Cabezas, J, Carvalhana, S, Cortez-Pinto, H, Costa, A, Degre, D, Fernandez-Carillo, C, Ganne-Carrie, N, Garcia-Tsao, G, Genesca, J, Koskinas, J, Lanthier, N, Louvet, A, Lozano, JJ, Lucey, MR, Masson, S, Mathurin, P, Mendez-Sanchez, N, Miquel, R, Moreno, C, Mounajjed, T, Odena, G, Kim, W, Sancho-Bru, P, Sands, RW, Szafranska, J, Verset, L, Schnabl, B, Sempoux, C, Shah, VJ, Shawcross, DL, Stauber, RE, Straub, BK, Verna, E, Tiniakos, D, Trepo, E, Vargas, V, Villanueva, C, Woosley, JT, Ziol, M, Mueller, S, Starkel, P, Bataller, R. Clinical, histological and molecular profiling of different stages of alcohol-related liver disease. GUT. 2022; 71(9)DOI:10.1136/gutjnl-2021-324295. PMID:34992134. IF:24.500(Q1/1D).
03/07/2022
Multimodality imaging evaluation of a primary cardiac epithelioid hemangioendothelioma
Marsico, S, Orellana-Fernandez, R, Tizon-Marcos, H, Mas-Stachurska, A, Solano, A, Zuccarino, F. Multimodality imaging evaluation of a primary cardiac epithelioid hemangioendothelioma. ACTA CARDIOLOGICA. 2022; 77(6)DOI:10.1080/00015385.2021.1908704. PMID:33827376. IF:1.600(Q4/9D).
01/02/2022
Urinary Proteomic Signature in Acute Decompensated Heart Failure: Advances into Molecular Pathophysiology
Diaz-Riera, E, Garcia-Arguinzonis, M, Lopez, L, Garcia-Moll, X, Badimon, L, Padro, T. Urinary Proteomic Signature in Acute Decompensated Heart Failure: Advances into Molecular Pathophysiology. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(4)DOI:10.3390/ijms23042344. PMID:35216460. IF:5.600(Q1/3D).